Literature DB >> 12875987

Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.

Iris Behrmann1, Susanne Wallner, Waraporn Komyod, Peter C Heinrich, Marion Schuierer, Reinhard Buettner, Anja-Katrin Bosserhoff.   

Abstract

Homozygous deletions of human chromosomal region 9p21 occur frequently in malignant melanoma and are associated with the loss of the tumor suppressor genes p16(INK4a) and p15(INK4b). In the same chromosomal region the methylthioadenosine phosphorylase (MTAP) gene is localized and therefore may also serve as a tumor suppressor gene. The aim of this study was to analyze MTAP mutations and expression patterns in malignant melanomas. To examine the MTAP gene and expression of MTAP protein we screened 9 human melanoma cell lines and primary human melanocytes by reverse transcriptase-polymerase chain reaction, sequencing, and immunoblotting. Analyzing the melanoma cell lines we found significant down-regulation of MTAP mRNA expression. In only one cell line, HTZ19d, this was due to homozygous deletion of exon 2 to 8 whereas in the other cell lines promoter hypermethylation was detected. MTAP expression was further analyzed in vivo by immunohistochemical staining of 38 tissue samples of benign melanocytic nevi, melanomas, and melanoma metastases. In summary, we demonstrate significant inverse correlation between MTAP protein expression and progression of melanocytic tumors as the amount of MTAP protein staining decreases from benign melanocytic nevi to metastatic melanomas. Our results suggest an important role of MTAP inactivation in the development of melanomas. This finding may be of great clinical significance because recently an association between MTAP activity and interferon sensitivity has been suggested.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875987      PMCID: PMC1868213          DOI: 10.1016/S0002-9440(10)63695-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.

Authors:  D J Wong; M T Barrett; R Stöger; M J Emond; B J Reid
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

2.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.

Authors:  W Remmele; U Hildebrand; H A Hienz; P J Klein; M Vierbuchen; L J Behnken; B Heicke; E Scheidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 3.  Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials.

Authors:  Marko B Lens; Martin Dawes
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

4.  The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.

Authors:  W M Stadler; O I Olopade
Journal:  Urol Res       Date:  1996

5.  The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia.

Authors:  Y Hori; H Hori; Y Yamada; C J Carrera; M Tomonaga; S Kamihira; D A Carson; T Nobori
Journal:  Int J Cancer       Date:  1998-01-05       Impact factor: 7.396

Review 6.  Adjuvant therapy for patients with high-risk malignant melanoma.

Authors:  Edward F McClay
Journal:  Semin Oncol       Date:  2002-08       Impact factor: 4.929

7.  MTAP gene deletion in endometrial cancer.

Authors:  Y F Wong; T K Chung; T H Cheung; T Nobori; A M Chang
Journal:  Gynecol Obstet Invest       Date:  1998       Impact factor: 2.031

8.  Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.

Authors:  Z H Chen; H Zhang; T M Savarese
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

9.  Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA.

Authors:  A Blesch; A K Bosserhoff; R Apfel; C Behl; B Hessdoerfer; A Schmitt; P Jachimczak; F Lottspeich; R Buettner; U Bogdahn
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

10.  Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines.

Authors:  N Kamatani; D A Carson
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

View more
  44 in total

1.  Functional modulation of IGF-binding protein-3 expression in melanoma.

Authors:  Altaf A Dar; Shahana Majid; Mehdi Nosrati; David de Semir; Scot Federman; Mohammed Kashani-Sabet
Journal:  J Invest Dermatol       Date:  2010-04-01       Impact factor: 8.551

2.  Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma.

Authors:  Yuwaraj Kadariya; Bu Yin; Baiqing Tang; Susan A Shinton; Eoin P Quinlivan; Xiang Hua; Andres Klein-Szanto; Tahseen I Al-Saleem; Craig H Bassing; Richard R Hardy; Warren D Kruger
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

3.  Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.

Authors:  Pedro Andreu-Pérez; Rosaura Esteve-Puig; Carlos de Torre-Minguela; Marta López-Fauqued; Joan Josep Bech-Serra; Stephan Tenbaum; Elena R García-Trevijano; Francesc Canals; Glenn Merlino; Matías A Avila; Juan A Recio
Journal:  Sci Signal       Date:  2011-09-13       Impact factor: 8.192

4.  Counting process-based dimension reduction methods for censored outcomes.

Authors:  Qiang Sun; Ruoqing Zhu; Tao Wang; Donglin Zeng
Journal:  Biometrika       Date:  2019-01-07       Impact factor: 2.445

5.  A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.

Authors:  Changzheng Du; Landon J Hansen; Simranjit X Singh; Feiyifan Wang; Ran Sun; Casey J Moure; Kristen Roso; Paula K Greer; Hai Yan; Yiping He
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

6.  Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Xueying Liang; Ruth M Pfeiffer; William Wheeler; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

7.  Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.

Authors:  R Bauer; P J Wild; S Meyer; F Bataille; A Pauer; M Klinkhammer-Schalke; F Hofstaedter; A K Bosserhoff
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

8.  Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines.

Authors:  Marion M Schuierer; Elisabeth Graf; Ken-Ichi Takemaru; Wolfgang Dietmaier; Anja-Katrin Bosserhoff
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

9.  Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells.

Authors:  Frederik C Henrich; Katrin Singer; Kerstin Poller; Luise Bernhardt; Carolin D Strobl; Katharina Limm; Axel P Ritter; Eva Gottfried; Simon Völkl; Benedikt Jacobs; Katrin Peter; Dimitrios Mougiakakos; Katja Dettmer; Peter J Oefner; Anja-Katrin Bosserhoff; Marina P Kreutz; Michael Aigner; Andreas Mackensen
Journal:  Oncoimmunology       Date:  2016-06-10       Impact factor: 8.110

Review 10.  Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease.

Authors:  Francesca Aguilo; Serena Di Cecilia; Martin J Walsh
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.